Published in Clinical Oncology Week, June 27th, 2011
"Eligibility for CCRT included tumor size >4 cm and/or lymph node enlargement over a minimum diameter of 1 cm. Tumor size (>= 5.2 cm) and age (<48 years) were independent predictive factors for locoregional recurrence by multivariate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.